Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global narcolepsy drugs market reached a value of US$ 2.84 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.5 Billion by 2027, exhibiting a CAGR of 7.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.

Narcolepsy Drugs Market Trends:

The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, disease type and therapeutic type.

Breakup by Type:

  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy
     

Breakup by Disease Type:

  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others
     

Breakup by Therapeutic Type:

  • Sodium Oxybate
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitor
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Disease Type, Therapeutic Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global narcolepsy drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global narcolepsy drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the therapeutic type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global narcolepsy drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Narcolepsy Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Narcolepsy with Cataplexy
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Narcolepsy without Cataplexy
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Secondary Narcolepsy
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Disease Type
    7.1    Daytime Extreme Sleepiness
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cataplexia
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Therapeutic Type
    8.1    Sodium Oxybate
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Central Nervous System Stimulants
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Tricyclic Antidepressants
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Selective Serotonin Reuptake Inhibitor
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Avadel Pharmaceuticals plc
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Axsome Therapeutics Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Bioprojet Pharma
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Graymark Healthcare Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Jazz Pharmaceuticals plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Ligand Pharmaceuticals Incorporated
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Novartis AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    SHIONOGI & Co. Ltd.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Takeda Pharmaceutical Company Limited
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2021
Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2021
Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million US$), 2022-2027
Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
Table 7: Global: Narcolepsy Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links